Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study.

Bamias, Aristotelis; Davis, Ian; Galsky, Matthew; Arranz, José; Kikuchi, Eiji; Grande, Enrique; Del Muro, Xavier; Park, Se; De Giorgi, Ugo; Alekseev, Boris; Mencinger, Marina; Izumi, Kouji; Schutz, Fabio; Puente, Javier; Li, Jian-Ri; Panni, Stefano; Gumus, Mahmut; Özgüroğlu, MUSTAFA; Mariathasan, Sanjeev; Poloz, Yekaterina; Bene-Tchaleu, Fabiola; Lee, Chooi; Bernhard, Sandrine; De Santis, Maria

doi:10.1016/s1470-2045(23)00539-9

Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study.

Bamias A., Davis I. D., Galsky M. D., Arranz J. Á., Kikuchi E., Grande E., ...Daha Fazla

The Lancet. Oncology, cilt.25, sa.1, ss.46-61, 2024 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 25 Sayı: 1
Basım Tarihi: 2024
Doi Numarası: 10.1016/s1470-2045(23)00539-9
Dergi Adı: The Lancet. Oncology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, MEDLINE
Sayfa Sayıları: ss.46-61
İstanbul Üniversitesi-Cerrahpaşa Adresli: Hayır

Özet

An extension of dimensional regularization to the case of compact dimensions is presented. The procedure preserves the Kaluza-Klein tower structure, but has a regulator specific to the compact dimension. Possible 5 and 4 dimensional divergent as well as manifest finite contributions of (one-loop) Feynman graphs can easily be identified in this scheme.